Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nat Thorogood"'
Autor:
Angela Meade, Elena Frangou, Babak Choodari-Oskooei, James Larkin, Tom Powles, Grant D. Stewart, Laurence Albiges, Axel Bex, Toni K. Choueiri, Ian D. Davis, Tim Eisen, Alison Fielding, Craig Gedye, David J. Harrison, Rick Kaplan, Salena Mulhere, Paul Nathan, Grisma Patel, Jay Patel, Hannah Plant, Alastair Ritchie, Hannah Rush, Clare Shakeshaft, Martin R. Stockler, Cristina Suarez, Jemima Thompson, Nat Thorogood, Balaji Venugopal, Mahesh K.B. Parmar
Publikováno v:
Contemporary Clinical Trials Communications, Vol 42, Iss , Pp 101381- (2024)
Clinical trials to establish the efficacy of new agents in the adjuvant cancer setting typically take many years to complete. During that time, external factors can impact recruitment and reporting plans. An example is a new standard of care becoming
Externí odkaz:
https://doaj.org/article/152a532dd63f4c618fd32817ead311e1
Autor:
Laurence Albiges, Martin R. Stockler, Grant D. Stewart, Alastair W. S. Ritchie, Sarah Scovell, Tim Eisen, Salena Mulhere, Mahesh K. B. Parmar, Ben Smith, Brian I. Rini, David J. Harrison, Richard Kaplan, Thomas Powles, Nat Thorogood, Hanna Bryant, Anita McWhirter, Bhavna Oza, Alison Fielding, James Larkin, Angela M. Meade, Axel Bex, Ian D. Davis, Clare Shakeshaft, Babak Choodari-Oskooei, Paul Nathan, Eleni Frangou, Toni K. Choueiri
Publikováno v:
Contemporary Clinical Trials
Background 20–60% of patients with initially locally advanced Renal Cell Carcinoma (RCC) develop metastatic disease despite optimal surgical excision. Adjuvant strategies have been tested in RCC including cytokines, radiotherapy, hormones and oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b398c819f256a4095399e1c7d91222e7
https://hdl.handle.net/10023/23999
https://hdl.handle.net/10023/23999
Autor:
Richard Kaplan, Hanna Bryant, Mahesh K. B. Parmar, Paul Nathan, Martin R. Stockler, Ian D. Davis, James Larkin, David J. Harrison, Salena Mulhere, Bhavna Oza, Alison Fielding, Babak Choodari-Oskooei, Grant D. Stewart, Tim Eisen, Sarah Scovell, Nat Thorogood, Toni K. Choueiri, Anita McWhirter, Laurence Albiges, Brian I. Rini, Thomas Powles, Ben Smith, Eleni Frangou, Clare Shakeshaft, Alastair W. S. Ritchie, Axel Bex, Angela M. Meade
Publikováno v:
Contemporary clinical trials. 108
AstraZeneca LP have provided an educational grant for the trial and free of charge durvalumab and tremelimumab. A small grant is also provided by Kidney Cancer UK. MRC CTU at UCL provides funding for staff working on the trial. The development of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0194c3ee0d4a13bc0ec0088f3a6189b2
https://pubmed.ncbi.nlm.nih.gov/34538401
https://pubmed.ncbi.nlm.nih.gov/34538401